Cutting-Edge Updates in Cardiac Amyloidosis: What’s New for Patients

แชร์
ฝัง
  • เผยแพร่เมื่อ 4 ธ.ค. 2024
  • Join our expert faculty to hear about newly-approved drug therapy for patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
    - - - -
    Faculty: Michelle M. Kittleson, MD, PhD
    Faculty: Ahmad Masri, MD, MS
    - - - -
    Earn free 0.50 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event.
    Click the link to view the Accreditation and Disclosure details before participating: Medscape.org/viewarticle/1001970.
    Supported by an independent educational grant from BridgeBio.
  • บันเทิง

ความคิดเห็น •